Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Cancer Epidemiol. 2021 Mar 20;72:101930. doi: 10.1016/j.canep.2021.101930

Table 1.

Background characteristics of the weighted survey participants, the prevalence of cervical cancer screening, and the multivariable-adjusted prevalence ratio by country and survey year (N=28,976)

All Participants Cervical Cancer Screening Multivariable adjusted analysis

Countries Survey Year Na (%b) Nc (%) (aPR) (95% CI) P-Value
Overall 28,976 5,512 (19.0)
Benin 2017–18 5,708 (19.7) 38 (0.7) ref.
Ivory Coast 2011–12 2,968 (10.2) 94 (3.2) 3.14 (2.05, 4.82) <.001
Kenya 2014 9,129 (31.5) 1,943 (21.3) 18.07 (12.45, 26.22) <.001
Namibia 2013 4,872 (16.8) 2,237 (45.9) 37.13 (25.50, 54.05) <.001
Zimbabwe 2015 6,299 (21.7) 1,200 (19.1) 18.12 (12.41, 26.46) <.001

Na = Weighted sample size of the combined dataset that is represented by that survey for each country

%b = The % of the combined dataset that is represented by that survey.

Nc= Prevalence of cervical cancer screening.

ref=reference

STI: Sexually transmissible infection

Model fully adjusted for country, health insurance coverage (yes/no), pregnancy status (yes/no), breastfeeding status (yes/no), age (categorical), education status (categorical), marital status (categorical), wealth index status (categorical), place of residence (urban/rural), employment status (yes/no), number of living children (categorical), STI (yes/no), contraceptive use (yes/no), sexually active in the last 4 weeks (categorical), household having a radio (yes/no), household having a television (yes/no), visited health care facility in the last 12 months (yes/no)